Unlikely to cause harm — often a labeling or packaging issue.
Incorrect/Undeclared Excipient: There is a potential an incorrect grade of excipient was used during manufacturing.
| Brand name | VALSARTAN |
| Generic name | VALSARTAN |
| Active ingredient(s) | VALSARTAN |
| Distributed by / for | Jubilant Cadista Pharmaceuticals, Inc. |
| NDC | 59746-363-90 |
| Full product label | Valsartan Tablets USP, 320 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd Roorkee 0247661 India, Marketed by: Jubilant Cardista Pharmaceuticals Inc. Salisbury, MD 21801, USA, NDC 59746-363-90 |
| Recalling firm | Jubilant Cadista Pharmaceuticals, Inc. |
| Distribution | Product was distributed throughout the United States to wholesalers and retailers. |
| Quantity | 7,048 bottles |
| Recall initiated | 2018-08-14 |
| Report date | 2018-08-29 |
| Recall completed | 2020-01-08 |
| Recall number | D-1106-2018 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | Salisbury MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗